The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of natural cytotoxicity receptors with eosinophil surface ligands

Frontiers in Immunology

Volumn 8, Issue APR, 2017, Pages

  Pesce, Silvia ^a   Thoren, Fredrik B ^b   Cantoni, Claudia ^a,c   Prato, Carola ^a,e   Moretta, Lorenzo ^d   Moretta, Alessandro ^a,d   Marcenaro, Emanuela ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c G GASLINI INSTITUTE   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cross talk; Cytotoxicity; Dendritic cells; Eosinophils; Innate cells; Natural cytotoxicity receptor; NK cells

Indexed keywords

B7 H6 PROTEIN; CD2 ANTIGEN; CD48 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 12; INTERLEUKIN 15; L SELECTIN; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NECTIN 2; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; UL16 BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ISOLATION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOLYSIS; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FLOW CYTOMETRY; HEK293T CELL LINE; HUMAN; HUMAN CELL; IMMUNOCYTOTOXICITY; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MOLECULAR INTERACTION; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; POLARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; UPREGULATION;

EID: 85018451162     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00510     Document Type: Article

References (76)

1. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med (1997) 186(7):1129-36. doi: 10.1084/jem.186.7.1129
2. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 190(10):1505-16. doi:10.1084/jem.190.10.1505
3. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 19:197-223. doi:10.1146/annurev.immunol.19.1.197
4. Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity (2007) 27(6):965-74. doi:10.1016/j.immuni.2007.10.010
5. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 206(7):1495-503. doi:10.1084/jem.20090681
6. Baychelier F, Sennepin A, Ermonval M, Dorgham K, Debre P, Vieillard V. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood (2013) 122(17):2935-42. doi:10.1182/blood-2013-03-489054
7. Arnon TI, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol (2006) 16(5):348-58. doi:10.1016/j.semcancer.2006.07.005
8. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A. Surface NK receptors and their ligands on tumor cells. Semin Immunol (2006) 18(3):151-8. doi:10.1016/j.smim.2006.03.002
9. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol (1996) 14:619-48. doi:10.1146/annurev.immunol.14.1.619
10. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol (1999) 17:875-904. doi:10.1146/annurev.immunol.17.1.875
11. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol (2001) 19:291-330. doi:10.1146/annurev.immunol.19.1.291
12. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 5(3):201-14. doi:10.1038/nri1570
13. Agaugue S, Marcenaro E, Ferranti B, Moretta L, Moretta A. Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood (2008) 112(5):1776-83. doi:10.1182/blood-2008-02-135871
14. Marcenaro E, Ferranti B, Falco M, Moretta L, Moretta A. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int Immunol (2008) 20(9):1155-67. doi:10.1093/Intimm/Dxn073
15. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331(6013):44-9. doi:10.1126/Science.1198687
16. Riise RE, Bernson E, Aurelius J, Martner A, Pesce S, Della Chiesa M, et al. TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses. J Immunol (2015) 195(3):1121-8. doi:10.4049/jimmunol.1500709
17. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med (2002) 195(3):F9-14. doi:10.1084/jem.20012040
18. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol (2002) 2(12):957-64. doi:10.1038/nri956
19. Ferlazzo G, Moretta L. Dendritic cell editing by natural killer cells. Crit Rev Oncog (2014) 19(1-2):67-75. doi:10.1615/CritRevOncog.2014010827
20. Marcenaro E, Dondero A, Moretta A. Multi-directional cross-regulation of NK cell function during innate immune responses. Transpl Immunol (2006) 17(1):16-9. doi:10.1016/j.trim.2006.09.019
21. Della Chiesa M, Marcenaro E, Sivori S, Carlomagno S, Pesce S, Moretta A. Human NK cell response to pathogens. Semin Immunol (2014) 26(2):152-60. doi:10.1016/j.smim.2014.02.001
22. Marcenaro E, Della Chiesa M, Bellora F, Parolini S, Millo R, Moretta L, et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol (2005) 174(7):3992-8. doi:10.4049/jimmunol.174.7.3992
23. Marcenaro E, Ferranti B, Moretta A. NK-DC interaction: on the usefulness of auto-aggression. Autoimmun Rev (2005) 4(8):520-5. doi:10.1016/j.autrev.2005.04.015
24. Mailliard RB, Alber SM, Shen H, Watkins SC, Kirkwood JM, Herberman RB, et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med (2005) 202(7):941-53. doi:10.1084/jem.20050128
25. Ali TH, Pisanti S, Ciaglia E, Mortarini R, Anichini A, Garofalo C, et al. Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat Commun (2014) 5:5639. doi:10.1038/ncomms6639
26. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol (2004) 5(12):1260-5. doi:10.1038/ni1138
27. Munitz A, Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy (2004) 59(3):268-75. doi:10.1111/j.1398-9995.2003.00442.x
28. Spencer LA, Szela CT, Perez SA, Kirchhoffer CL, Neves JS, Radke AL, et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol (2009) 85(1):117-23. doi:10.1189/jlb.0108058
29. Kvarnhammar AM, Cardell LO. Pattern-recognition receptors in human eosinophils. Immunology (2012) 136(1):11-20. doi:10.1111/j.1365-2567.2012.03556.x
30. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol (1993) 150(6):2554-62
31. Lucey DR, Nicholson-Weller A, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A (1989) 86(4):1348-51. doi:10.1073/pnas.86.4.1348
32. Akuthota P, Wang H, Weller PF. Eosinophils as antigen-presenting cells in allergic upper airway disease. Curr Opin Allergy Clin Immunol (2010) 10(1):14-9. doi:10.1097/ACI.0b013e328334f693
33. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 105(7):945-53. doi:10.1172/JCI8945
34. Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun (2006) 74(6):3232-8. doi:10.1128/IAI.02067-05
35. Wang HB, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol (2007) 179(11):7585-92. doi:10.4049/jimmunol.179.11.7585
36. Davis BP, Rothenberg ME. Eosinophils and cancer. Cancer Immunol Res (2014) 2(1):1-8. doi:10.1158/2326-6066.CIR-13-0196
37. Gatault S, Legrand F, Delbeke M, Loiseau S, Capron M. Involvement of eosinophils in the anti-tumor response. Cancer Immunol Immunother (2012) 61(9):1527-34. doi:10.1007/s00262-012-1288-3
38. Davoine F, Ferland C, Chakir J, Lee JE, Adamko DJ, Moqbel R, et al. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis. Int Arch Allergy Immunol (2006) 140(4):277-84. doi:10.1159/000093705
39. Hoontrakoon R, Chu HW, Gardai SJ, Wenzel SE, McDonald P, Fadok VA, et al. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol (2002) 26(4):404-12. doi:10.1165/ajrcmb.26.4.4517
40. Park YM, Bochner BS. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res (2010) 2(2):87-101. doi:10.4168/aair.2010.2.2.87
41. Thoren FB, Riise RE, Ousback J, Della Chiesa M, Alsterholm M, Marcenaro E, et al. Human NK cells induce neutrophil apoptosis via an NKp46-and Fas-dependent mechanism. J Immunol (2012) 188(4):1668-74. doi:10.4049/jimmunol.1102002
42. Reymond N, Imbert AM, Devilard E, Fabre S, Chabannon C, Xerri L, et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med (2004) 199(10):1331-41. doi:10.1084/jem.20032206
43. Falco M, Marcenaro E, Romeo E, Bellora F, Marras D, Vely F, et al. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur J Immunol (2004) 34(6):1663-72. doi:10.1002/eji.200424886
44. Pesce S, Tabellini G, Cantoni C, Patrizi O, Coltrini D, Rampinelli F, et al. B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape. Oncoimmunology (2015) 4(4):e1001224. doi:10.1080/2162402X.2014.1001224
45. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol (2005) 175(12):7989-95. doi:10.4049/jimmunol.175.12.7989
46. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood (2006) 107(5):1996-2003. doi:10.1182/blood-2005-07-2926
47. Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, et al. 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol (2005) 174(1):110-8. doi:10.4049/jimmunol.174.1.110
48. Hansel TT, De Vries IJ, Iff T, Rihs S, Wandzilak M, Betz S, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods (1991) 145(1-2):105-10. doi:10.1016/0022-1759(91)90315-7
49. Awad A, Yassine H, Barrier M, Vorng H, Marquillies P, Tsicopoulos A, et al. Natural killer cells induce eosinophil activation and apoptosis. PLoS One (2014) 9(4):e94492. doi:10.1371/journal.pone.0094492
50. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest (1997) 99(2):178-84. doi:10.1172/JCI119145
51. Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, et al. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood (2013) 122(3):394-404. doi:10.1182/blood-2013-01-481705
52. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood (2005) 106(7):2252-8. doi:10.1182/blood-2005-03-1154
53. Marcenaro E, Cantoni C, Pesce S, Prato C, Pende D, Agaugue S, et al. Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood (2009) 114(19):4108-16. doi:10.1182/blood-2009-05-222265
54. Marcenaro E, Pesce S, Sivori S, Carlomagno S, Moretta L, Moretta A. KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts. Blood (2013) 121(17):3396-401. doi:10.1182/blood-2012-09-458752
55. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med (2002) 195(3):343-51. doi:10.1084/jem.20011149
56. Vitale M, Della Chiesa M, Carlomagno S, Romagnani C, Thiel A, Moretta L, et al. The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol (2004) 34(6):1715-22. doi:10.1002/eji.200425100
57. Morandi B, Mortara L, Chiossone L, Accolla RS, Mingari MC, Moretta L, et al. Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. PLoS One (2012) 7(6):e39170. doi:10.1371/journal.pone.0039170
58. Marcenaro E, Carlomagno S, Pesce S, Della Chiesa M, Parolini S, Moretta A, et al. NK cells and their receptors during viral infections. Immunotherapy (2011) 3(9):1075-86. doi:10.2217/imt.11.99
59. Bellora F, Castriconi R, Dondero A, Reggiardo G, Moretta L, Mantovani A, et al. The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc Natl Acad Sci U S A (2010) 107(50):21659-64. doi:10.1073/pnas.1007654108
60. El-Shazly AE, Lefebvre PP. Modulation of NK cell autocrine-induced eosinophil chemotaxis by interleukin-15 and vitamin D(3): a possible NK-eosinophil crosstalk via IL-8 in the pathophysiology of allergic rhinitis. Mediators Inflamm (2011) 2011:373589. doi:10.1155/2011/373589
61. El-Shazly AE, Doloriert HC, Bisig B, Lefebvre PP, Delvenne P, Jacobs N. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue. Clin Exp Allergy (2013) 43(3):322-31. doi:10.1111/cea.12022
62. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med (2013) 5(174):174ra26. doi:10.1126/scitranslmed.3004812
63. Momose T, Okubo Y, Horie S, Takashi S, Tsukadaira A, Suzuki J, et al. Interferon-gamma increases CD62L expression on human eosinophils. Int Arch Allergy Immunol (1999) 120(Suppl 1):30-3. doi:10.1159/000053590
64. Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol (2004) 113(1):30-7. doi:10.1016/j.jaci.2003.10.050
65. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 38(5):709-50. doi:10.1111/j.1365-2222.2008.02958.x
66. Akuthota P, Wang HB, Spencer LA, Weller PF. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy (2008) 38(8):1254-63. doi:10.1111/j.1365-2222.2008.03037.x
67. Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res (2011) 343(1):57-83. doi:10.1007/s00441-010-1049-6
68. Jacobsen EA, Helmers RA, Lee JJ, Lee NA. The expanding role(s) of eosinophils in health and disease. Blood (2012) 120(19):3882-90. doi:10.1182/blood-2012-06-330845
69. Shi HZ. Eosinophils function as antigen-presenting cells. J Leukoc Biol (2004) 76(3):520-7. doi:10.1189/jlb.0404228
70. Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, et al. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol (2008) 121(2):479-85. doi:10.1016/j.jaci.2007.09.047
71. Walsh ER, August A. Eosinophils and allergic airway disease: there is more to the story. Trends Immunol (2010) 31(1):39-44. doi:10.1016/j.it.2009.10.001
72. Spencer LA, Weller PF. Eosinophils and Th2 immunity: contemporary insights. Immunol Cell Biol (2010) 88(3):250-6. doi:10.1038/icb.2009.115
73. Valerius T, Repp R, Kalden JR, Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol (1990) 145(9):2950-8
74. Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5. Immunol Lett (2008) 118(1):88-95. doi:10.1016/j.imlet.2008.03.005
75. Handzel ZT, Busse WW, Sedgwick JB, Vrtis R, Lee WM, Kelly EA, et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol (1998) 160(3):1279-84
76. Garro AP, Chiapello LS, Baronetti JL, Masih DT. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection. Immunology (2011) 134(2):198-213. doi:10.1111/j.1365-2567.2011.03479.x